BOE Health Investment Management Co., Ltd.

BOE Health Service Business Group is affiliated with the listed company BOE Technology Group and was founded in 2014. The business group combines BOE's four core technologies accumulated over many years—display, sensing, artificial intelligence, and big data—with medicine and life science, engaging in cross-sector innovation to develop O2O medical services, mobile health, regenerative medicine, and integrated pharmaceuticals, integrating health park resources, and building a health insurance payment platform. With internationally advanced medical technology and high-quality medical services, it provides customers with pleasant and affordable health care services.
O2O Medical Services: Building digital hospitals (Grade III scale), comprehensive outpatient clinics, and digital clinics in Hefei, Chengdu, and other locations to construct a hierarchical diagnosis and treatment service system covering the full life cycle from prevention to diagnosis and treatment to rehabilitation.
Mobile Health: Using mobile health terminal devices such as non-invasive blood testing, non-invasive blood glucose testing, brainwave, and ECG detection products as ports, detecting data through smart terminals to predict health risks, issue treatment recommendation plans, and provide users with personalized diagnosis and treatment and health management plans.
Regenerative Medicine: Business covers three parts: cell engineering laboratory, cell preparation center, and clinical translation center. Producing regenerative cell sheet products that meet clinical application standards and can be used for the heart, cornea, skin, etc.
Integrated Pharmaceuticals: Focusing on developing medications in the fields of hepatobiliary, oncology, respiratory, and cardiovascular, as well as medical devices for orthopedics, cardiac, and ocular testing, committed to building an integrated platform for pharmaceutical and device development and marketing value chain.